高视医疗(02407)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02407 高视医疗

已收盘 09-10 15:50:57

4.690

+0.190

+4.22%

最高4.895	最低4.625	成交量1.35万
今开4.895	昨收4.500	日振幅6.00%
总市值6.94亿	流通市值6.94亿	总股本1.48亿
成交额6.35万	换手率0.01%	流通股本1.48亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02407","market":"HK","secType":"STK","nameCN":"高视医疗","latestPrice":4.69,"timestamp":1789026657864,"preClose":4.5,"halted":0,"volume":13500,"delay":0,"changeRate":0.04222222222222231,"floatShares":147970369,"shares":148000000,"eps":0.7709341111712262,"marketStatus":"已收盘","change":0.19,"latestTime":"09-10 15:50:57","open":4.895,"high":4.895,"low":4.625,"amount":63544,"amplitude":0.06,"askPrice":4.69,"askSize":1600,"bidPrice":4.345,"bidSize":100,"shortable":0,"etf":0,"ttmEps":0.6120843056463817,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1670774400000,"exchange":"SEHK","adjPreClose":4.5,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.594714,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02407","defaultTab":"news","newsList":[{"id":"1155245965","title":"高视医疗8月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1155245965","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155245965?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:51","pubTimestamp":1788252704,"startTime":"0","endTime":"0","summary":"高视医疗科技有限公司于2026年9月1日发布截至2026年8月31日的股份变动月报表。公告显示，公司法定/注册股本维持不变，截至报告期末注册股本为500,000,000股，面值每股USD 0.0001，总额为USD 50,000。报告期内未有新股份发行、回购或注销事宜，过去一个月公司股本结构整体保持稳定。公司确认，报告期内的所有证券发行或股份转让等事宜均已按照适用的上市规则及相关法律法规办理，并经公司董事会正式授权。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069146","title":"高视医疗(02407)公布中期业绩 股东应占溢利1727.2万元 同比减少54.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069146","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662069146?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:05","pubTimestamp":1787911549,"startTime":"0","endTime":"0","summary":"智通财经APP讯，高视医疗(02407)公布2026年中期业绩，收入为5.95亿元，同比减少8.9%。公司股东应占溢利1727.2万元，同比减少54.52%;每股盈利0.12元。公告称，受国家政策引导下市场需求结构转变和海外飞秒激光辅助白内障手术产品代理合作终止等多重不利因素共同作用的影响，集团经销产品收入出现下滑。但在压力之下，集团自有产品收入实现4.6%的增长，契合集团的发展战略。2026年下半年，预期将有多款自研产品实现量产上市，带动收入的持续增长，助力集团整体业绩改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02407","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162533645","title":"高视医疗2026年上半年营收5.95亿元，经调整净利润0.15亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162533645","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162533645?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:02","pubTimestamp":1787911336,"startTime":"0","endTime":"0","summary":"高视医疗发布的2026年上半年财报显示，报告期内公司实现营收5.95亿元，同比下降8.9%。经调整净利润为0.15亿元，同比下降57.9%。毛利约为2.88亿元，同比下降8.6%，毛利率由上年同期的48.3%小幅提升至48.5%。公司持续保持稳健的财务状况，截至期末现金及现金等价物余额为3.00亿元，较2025年末减少28.7%，主要因报告期内陆续偿还境内外贷款本金及利息所致。报告期内，持续的研发投入使多款产品已获得注册证或进入审批阶段，为后续收入贡献奠定基础。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"高视医疗2026年上半年营收5.95亿元，经调整净利润0.15亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136496130","title":"高视医疗（02407）公告将于8月28日召开董事会审议2026年中期业绩及股息分派","url":"https://stock-news.laohu8.com/highlight/detail?id=1136496130","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136496130?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:41","pubTimestamp":1787046085,"startTime":"0","endTime":"0","summary":"高视医疗科技有限公司（02407）8月18日发布董事会会议通告，公司董事会将于2026年8月28日（星期五）召开会议，主要议程包括：一、审议及批准本集团截至2026年6月30日止六个月的中期业绩及其发布；二、研究派发中期股息（如有）的事宜。此次会议由公司主席兼执行董事高铁塔先生召集。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660674487","title":"高视医疗(02407.HK)附属与HEIDELBERG就角膜共聚焦显微镜T3签署五年期独家代理协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2660674487","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660674487?lang=zh_cn&edition=full","pubTime":"2026-08-17 20:17","pubTimestamp":1786969027,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192405820","title":"高视医疗（02407）子公司与HEIDELBERG签署五年期全球（除中国）独家代理协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1192405820","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192405820?lang=zh_cn&edition=full","pubTime":"2026-08-17 20:16","pubTimestamp":1786968971,"startTime":"0","endTime":"0","summary":"2026年8月17日，高视医疗科技有限公司发布自愿公告称，其全资子公司高视创新科技有限公司已与德国HEIDELBERG ENGINEERING GmbH签订为期五年的独家代理协议。根据协议，HEIDELBERG将在除中华人民共和国以外的全球范围内独家代理销售高视创新自主研发并生产的角膜共聚焦显微镜T3，并负责市场推广及相关技术服务。公告同时指出，自1998年起，高视医疗一直是HEIDELBERG旗下眼科成像系统在中国的独家经销商，双方长期保持重要业务合作关系。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188329725","title":"高视医疗获T3角膜共焦显微镜全球独家代理权（中国除外）","url":"https://stock-news.laohu8.com/highlight/detail?id=1188329725","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188329725?lang=zh_cn&edition=full","pubTime":"2026-08-17 20:12","pubTimestamp":1786968760,"startTime":"0","endTime":"0","summary":"高视医疗与Heidelberg达成重要合作，将出任T3角膜共焦显微镜在全球范围内的独家经销商，中国市场则不在此次合作范围内。根据双方达成的安排，高视医疗将全面负责T3角膜共焦显微镜在海外市场的推广、销售及服务支持，从而为全球眼科诊疗技术升级注入新动力。未来，随着T3角膜共焦显微镜在全球更多医疗机构的落地应用，高视医疗有望借此契机强化自身在高端眼科设备领域的品牌影响力与市场渗透力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167766991","title":"高视医疗（02407）更新公司章程　反映开曼注册处更名","url":"https://stock-news.laohu8.com/highlight/detail?id=1167766991","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167766991?lang=zh_cn&edition=full","pubTime":"2026-08-17 20:02","pubTimestamp":1786968121,"startTime":"0","endTime":"0","summary":"高视医疗科技有限公司8月17日在港交所公告称，已根据股东于2026年5月28日举行的股东周年大会所授授权，完成第七次修订并重列组织章程大纲及细则。此次修订的核心内容是把公司于开曼群岛的主要股份过户登记处名称由“Harneys Fiduciary  Limited”变更为“Ascentium  Limited”。\\n\\n公司已于2026年4月27日公告相关注册处名称变更事宜，并在2026年4月29日向股东发出通函及股东周年大会议案，随后于2026年5月28日发布了投票表决结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656129378","title":"高视医疗(02407)预计上半年收入同比减少约7.1%至10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656129378","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656129378?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:39","pubTimestamp":1785753579,"startTime":"0","endTime":"0","summary":"智通财经APP讯，高视医疗(02407)发布公告，预期集团截至2026年6月30日止六个月将取得收入约人民币5.832亿元至6.07亿元，相比截至2025年6月30日止六个月收入约人民币6.531亿元，减少约7.1%至10.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475350.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166335379","title":"高视医疗（02407）发布补充盈利警告：上半年营收预计降至约5.83亿至6.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166335379","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166335379?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:35","pubTimestamp":1785753353,"startTime":"0","endTime":"0","summary":"高视医疗科技有限公司（02407）8月3日发布补充公告称，基于对截至2026年6月30日止六个月未经过审的综合管理账目的初步审阅，预计该期收入约为5.83亿至6.07亿元，较2025年同期的约6.53亿元减少约7.1%至10.7%。\\n\\n公司表示，业绩变动的主要原因与7月23日已公布的盈利警告公告所述因素一致。除本次补充信息外，原盈利警告公告的其他内容保持不变。\\n\\n高视医疗指出，目前仍在编制2026年中期业绩，相关财务数据尚未经核数师或审计委员会审核。公司预计将于2026年8月底披露完整的中期业绩报告。\\n\\n公司提醒投资者审慎决策。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107689746","title":"高视医疗7月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1107689746","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107689746?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:52","pubTimestamp":1785747149,"startTime":"0","endTime":"0","summary":"高视医疗科技有限公司于2026年8月3日披露了截至2026年7月31日止月份的证券变动月报表。报告显示，公司截至本月底法定注册股本维持在500,000,000股，面值为每股0.0001美元，总额保持不变，仍为50,000美元。从已发行股份及库藏股份情况来看，本月底已发行股份数和上月底保持一致，均为147,887,869股，库藏股份数量为0股。截至7月末，公司股本结构保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140174052","title":"高视医疗科技有限公司（02407）发布盈利警告：上半年净利预计同比下滑逾五成","url":"https://stock-news.laohu8.com/highlight/detail?id=1140174052","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140174052?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:21","pubTimestamp":1784812885,"startTime":"0","endTime":"0","summary":"2026年7月23日，高视医疗科技有限公司公告称，基于对未经审计综合管理账目的初步审阅，预计截至2026年6月30日止六个月录得净利润约人民币13.9百万元至16.7百万元，较2025年同期的约人民币35.9百万元下降约53.5%至61.3%。\\n\\n公告显示，公司预计2026年上半年收入约人民币5.42亿元至6.49亿元，较2025年同期的约人民币6.53亿元减少约0.7%至17.1%。\\n\\n同期，公司预计汇兑损失增加约人民币7.8百万元至9.8百万元，进一步影响盈利水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653723897","title":"高视医疗(02407.HK)发盈警 预计中期利润净额约1390万元至1670万元 同比减少约53.5%至61.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653723897","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653723897?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:03","pubTimestamp":1784811828,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02407","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180630338","title":"高视医疗6月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1180630338","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180630338?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:56","pubTimestamp":1782982612,"startTime":"0","endTime":"0","summary":"高视医疗科技有限公司于2026年7月2日发布2026年6月股份变动月报表。公告显示，截至2026年6月30日，公司法定注册股本维持为5亿股普通股，面值每股0.0001美元，总额USD 50,000，与上月持平。公司上月底已发行股份数量为147,887,869股，本月无新增发行或回购注销，期末已发行股份总数仍为147,887,869股，表明公司当月无股份变动。该月报由公司主席兼执行董事高铁塔于2026年7月2日签署。公司未披露任何股权激励方案、可换股债券或其他股份变动安排。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640593026","title":"高视医疗(02407)获控股股东高铁塔转让3172.19万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640593026","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640593026?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:52","pubTimestamp":1780307540,"startTime":"0","endTime":"0","summary":"智通财经APP讯，高视医疗 发布公告，高视医疗科技有限公司获高铁塔先生通知，其全资拥有公司GAUSH HOLDING Ltd已 于2026年6月1日与Godax Ltd及Kleido Limited订立赠与契据，据此，赠与人将向受赠人转让3172.19万股每股面值0.0001美元的本公司股份，占本公司已发行股本总额约21.45%。股份转让的目的主要为于家族成员的间重新分配家族资产，并加强家族对本集团未来繁荣发展的共同承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02407","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155178456","title":"高视医疗更新5月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1155178456","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155178456?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:49","pubTimestamp":1780303748,"startTime":"0","endTime":"0","summary":"高视医疗科技有限公司于2026年6月1日发布2026年5月股份变动月报表，报告期为2026年5月1日至2026年5月31日。公告显示，公司上月底及本月底法定/注册股本均为500,000,000股，面值每股USD 0.0001，注册股本总额维持USD 50,000不变。同时，公司已发行普通股数为147,887,869股，与上月保持一致，库藏股数量为0股。高视医疗确认其公众持股量已满足香港联合交易所有限公司关于最低公众持股量的相关要求，并承诺严格遵守香港联交所《上市规则》及其他适用法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139279203","title":"高视医疗4月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1139279203","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139279203?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:48","pubTimestamp":1778057293,"startTime":"0","endTime":"0","summary":"高视医疗于2026年5月6日发布4月股份变动月报表。公告显示，公司本月未进行任何新增发行、回购或注销，股本结构维持稳定。高视医疗截至2026年4月30日的法定股本为500,000,000股普通股，面值每股0.0001美元，注册股本合计50,000美元，与上月保持一致。已发行股份为147,887,869股，总数同为147,887,869股，数量未发生变化。从报告内容来看，4月期间未发生股份购买、回购或注销情况，也无新增派发或行使的股份期权及认股权证。该公告由高铁塔签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166613078","title":"高视医疗拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1166613078","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166613078?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:42","pubTimestamp":1777473754,"startTime":"0","endTime":"0","summary":"高视医疗科技有限公司公告称，董事会建议将于2026年5月28日召开股东周年大会，审议一项股份购回授权，回购规模上限为不超过现有已发行股份总数的10%。根据公司最新披露，截至最后实际可行日期，公司已发行股份总数为147,887,869股，拟回购的上限数量约为14,788,786股。董事会认为，恰当行使股份购回授权有助于提升每股净值，符合公司及股东整体利益。董事会表示，若授权获得批准，将在资金与市场状况等合适时机考虑实施后续回购计划。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"高视医疗拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157922475","title":"高视医疗2025年度营收13.80亿元 净利润小幅增长至91.2百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157922475","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157922475?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:40","pubTimestamp":1777473621,"startTime":"0","endTime":"0","summary":"高视医疗科技有限公司于2017年11月1日根据开曼群岛法律注册成立，专注于眼科器械与耗材的研发、生产及销售，并于2022年12月12日在香港联合交易所主板上市。报告期内，公司收入为1,380.4百万元人民币，较上年度下降3.4%；同期净利润由2024年的88.5百万元人民币增至91.2百万元人民币，同比增长3.1%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"高视医疗2025年度营收13.80亿元 净利润小幅增长至91.2百万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02407"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630367177","title":"高视医疗(02407)：开曼群岛的主要股份过户登记处名称更改为“Ascentium (Cayman) Limited”","url":"https://stock-news.laohu8.com/highlight/detail?id=2630367177","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630367177?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:26","pubTimestamp":1777285610,"startTime":"0","endTime":"0","summary":"智通财经APP讯，高视医疗(02407)发布公告，自2026年4月 17日起，本公司于开曼群岛的主要股份过户登记处名称已由“Harneys Fiduciary (Cayman) Limited”更改为“Ascentium (Cayman) Limited”。本公司于开曼群岛的主要股份过户登记处地址维持不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02407"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gaush.com","stockEarnings":[{"period":"1week","weight":-0.0426},{"period":"1month","weight":-0.0625},{"period":"3month","weight":-0.0872},{"period":"6month","weight":-0.1313},{"period":"1year","weight":-0.4731},{"period":"ytd","weight":-0.4539}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":-0.0255},{"period":"3month","weight":0.0423},{"period":"6month","weight":-0.0075},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"高视医疗科技有限公司是一家主要从事眼科医疗器械及耗材的研发、制造及销售的投资控股公司。该公司经营四个分部。自有产品分部开发及生产手术设备及相关配套软件、内光透镜、眼科疾病诊断及治疗设备以及相关配套耗材。经销分部销售其他眼科医疗器械制造商生产的多功能诊断设备、眼底诊断、手术及治疗设备以及相关配套耗材。技术服务分部提供保修服务、维护服务及售后服务所用耗材。其他分部主要包括授出知识产权权限，以及提供临床研究组织相关服务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.077839},{"month":2,"riseRate":0.25,"avgChangeRate":-0.089792},{"month":3,"riseRate":0,"avgChangeRate":-0.202283},{"month":4,"riseRate":0.25,"avgChangeRate":-0.018051},{"month":5,"riseRate":0.25,"avgChangeRate":-0.04254},{"month":6,"riseRate":0.75,"avgChangeRate":-0.017526},{"month":7,"riseRate":0.75,"avgChangeRate":0.003225},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032102},{"month":9,"riseRate":0.25,"avgChangeRate":0.009744},{"month":10,"riseRate":0.333333,"avgChangeRate":0.02419},{"month":11,"riseRate":0,"avgChangeRate":-0.023256},{"month":12,"riseRate":0,"avgChangeRate":-0.064946}],"exchange":"SEHK","name":"高视医疗","nameEN":"GAUSH MEDITECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"高视医疗(02407)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供高视医疗(02407)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"高视医疗,02407,高视医疗股票,高视医疗股票老虎,高视医疗股票老虎国际,高视医疗行情,高视医疗股票行情,高视医疗股价,高视医疗股市,高视医疗股票价格,高视医疗股票交易,高视医疗股票购买,高视医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"高视医疗(02407)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供高视医疗(02407)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}